Oral contraceptive estrogen content and adverse effects.
The 1985 Health and Welfare Canada Report on Oral Contraceptives recommended oral contraceptives (OCs) containing 30-35 mcg of estrogen rather than 50 mcg as the preferred dosage for contraception. Many family physicians may regard these guidelines as mandatory when prescribing OCs, because of a presumption that pills of 50-mcg estrogen content carry a higher risk of disease. In this article, the epidemiologic evidence pertaining to a dose-response relationship between the estrogen dose of oral contraceptives and disease is critically reviewed. The review indicates that there is no incontrovertible evidence to support such a relationship. Implications of the recommendations in the Report for physicians and patients are discussed.
M
M
Russell
S
S
Ramcharan
Br Med J. 1980 May 10;280(6224):1157-61
7388443
Am J Med. 1984 Apr;76(4):557-61
6711569
Am J Epidemiol. 1975 Sep;102(3):197-208
1163525
Br Med J. 1970 Apr 25;2(5703):203-9
5443406
Br Med J (Clin Res Ed). 1986 Feb 22;292(6519):526
3081157
Fam Plann Perspect. 1974 Fall;6(4):230-3
4442571
Johns Hopkins Med J. 1982 May;150(5):165-9
7043034
Br J Obstet Gynaecol. 1979 Apr;86(4):325-9
373792
Am J Obstet Gynecol. 1976 Aug 15;125(8):1029-38
952300
Lancet. 1979 Apr 7;1(8119):743-7
85989
Br J Obstet Gynaecol. 1981 Aug;88(8):838-45
7260005
Lancet. 1980 May 24;1(8178):1097-101
6103437
Obstet Gynecol. 1982 Mar;59(3):299-302
7078875
Johns Hopkins Med J. 1982 May;150(5):170-6
7043035
Am J Epidemiol. 1983 Feb;117(2):153-9
6338705
Contraception. 1985 Jan;31(1):29-41
3987273
Clin Pharmacol Ther. 1979 Jul;26(1):129-41
445956